Iatrogenic botulism after botulinum meurotoxin exposure: A contemporary case series with clinical and electrophysiological insights
Abstract
Backgorund & Objective: Iatrogenic botulism is a rare but potentially serious complication of botulinum neurotoxin (BoNT) use, increasingly recognized in association with cosmetic and therapeutic applications. This study aimed to describe the clinical characteristics, diagnostic challenges, electrophysiological findings, management strategies, and outcomes of patients with iatrogenic botulism.
Methods: We retrospectively analyzed ten patients diagnosed with iatrogenic botulism who were evaluated and followed at a tertiary neurology center between 2019 and 2025. Demographic characteristics, indications for BoNT administration, time to symptom onset, initial clinical manifestations, electrophysiological findings, treatments, and clinical outcomes were systematically reviewed.
Results: The cohort consisted predominantly of female patients, with therapeutic and cosmetic indications—most commonly migraine prophylaxis and facial aesthetic procedures—being the leading causes of BoNT exposure. Initial symptoms included cranial nerve involvement such as ptosis, diplopia, dysarthria, and dysphagia, frequently accompanied by generalized weakness, blurred vision, nausea, and vomiting. Electrophysiological studies revealed presynaptic neuromuscular junction dysfunction, characterized by low-frequency decremental responses and high-frequency or post-exercise incremental responses on repetitive nerve stimulation, as well as increased jitter on single-fiber electromyography. Treatment…
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.